GLP-1 medications

The federal government will launch a temporary pilot called Medicare GLP-1 Bridge on July 1, 2026, making selected brand-name GLP-1 weight-loss drugs available to ce...

At the Great American State Fair on July 6, CMS Administrator Dr. Mehmet Oz told Fox News Digital he supports appropriate use of GLP-1 medications for weight loss, c...

A retrospective observational study to be presented at ENDO 2026 analyzed linked fitness-tracker and clinical data from 753 adults with obesity who started GLP-1 med...

Food companies such as Conagra (Healthy Choice) and Nestlé (Vital Pursuits) have begun labeling some frozen and packaged meals as "GLP-1 Friendly" to appeal to peopl...

A JAMA Network Open analysis of U.S. dietary supplement use from 1999–2023 (over 63,000 adults aged 20+) found overall supplement use rose from 51% to 60% of adults,...

Researchers presented a systematic review of five randomized controlled trials at ENDO 2026 examining the effects of GLP‑1 weight‑loss medications on hormonal and se...

At Paris Fashion Week, Oprah Winfrey was mocked online for walking in a way some described as like a "90-year-old." In a video clip she laughed off the criticism and...

Lindt & Sprüngli reported that households using GLP-1 weight-loss medications (such as Ozempic, Wegovy, Mounjaro and Zepbound) are accounting for disproportionate gr...

Harvard economist Rebecca Diamond analyzed panel data from the Understanding America Study to compare women who began taking GLP-1 drugs for weight loss with women w...

Mayim Bialik wrote an essay in The Free Press describing a severe adverse reaction after a single, low‑dose injection of a GLP‑1 medication. She said the reaction in...

Social media posts have promoted a gelatin-based drink as a low-cost appetite suppressant and compared its effects to GLP-1 weight-loss medications such as Ozempic. ...